-
Je něco špatně v tomto záznamu ?
Designing a dynamic dissolution method: a review of instrumental options and corresponding physiology of stomach and small intestine
M. Culen, A. Rezacova, J. Jampilek, J. Dohnal,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
PubMed
23494815
DOI
10.1002/jps.23494
Knihovny.cz E-zdroje
- MeSH
- farmaceutická chemie metody MeSH
- farmakokinetika * MeSH
- gastrointestinální trakt fyziologie MeSH
- léčivé přípravky chemie MeSH
- lidé MeSH
- rozpustnost MeSH
- tenké střevo fyziologie MeSH
- žaludek fyziologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Development of new pharmaceutical compounds and dosage forms often requires in vitro dissolution testing with the closest similarity to the human gastrointestinal (GI) tract. To create such conditions, one needs a suitable dissolution apparatus and the appropriate data on the human GI physiology. This review discusses technological approaches applicable in biorelevant dissolutions as well as the physiology of stomach and small intestine in both fasted and fed state, that is, volumes of contents, transit times for water/food and various solid oral dosage forms, pH, osmolality, surface tension, buffer capacity, and concentrations of bile salts, phospholipids, enzymes, and Ca(2+) ions. The information is aimed to provide clear suggestions on how these conditions should be set in a dynamic biorelevant dissolution test.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14051164
- 003
- CZ-PrNML
- 005
- 20140414093148.0
- 007
- ta
- 008
- 140401s2013 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/jps.23494 $2 doi
- 035 __
- $a (PubMed)23494815
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Culen, Martin
- 245 10
- $a Designing a dynamic dissolution method: a review of instrumental options and corresponding physiology of stomach and small intestine / $c M. Culen, A. Rezacova, J. Jampilek, J. Dohnal,
- 520 9_
- $a Development of new pharmaceutical compounds and dosage forms often requires in vitro dissolution testing with the closest similarity to the human gastrointestinal (GI) tract. To create such conditions, one needs a suitable dissolution apparatus and the appropriate data on the human GI physiology. This review discusses technological approaches applicable in biorelevant dissolutions as well as the physiology of stomach and small intestine in both fasted and fed state, that is, volumes of contents, transit times for water/food and various solid oral dosage forms, pH, osmolality, surface tension, buffer capacity, and concentrations of bile salts, phospholipids, enzymes, and Ca(2+) ions. The information is aimed to provide clear suggestions on how these conditions should be set in a dynamic biorelevant dissolution test.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a farmaceutická chemie $x metody $7 D002626
- 650 _2
- $a gastrointestinální trakt $x fyziologie $7 D041981
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a tenké střevo $x fyziologie $7 D007421
- 650 _2
- $a léčivé přípravky $x chemie $7 D004364
- 650 12
- $a farmakokinetika $7 D010599
- 650 _2
- $a rozpustnost $7 D012995
- 650 _2
- $a žaludek $x fyziologie $7 D013270
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Rezacova, Anna $u -
- 700 1_
- $a Jampilek, Josef $u -
- 700 1_
- $a Dohnal, Jiri $u -
- 773 0_
- $w MED00002895 $t Journal of pharmaceutical sciences $x 1520-6017 $g Roč. 102, č. 9 (2013), s. 2995-3017
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23494815 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140401 $b ABA008
- 991 __
- $a 20140414093243 $b ABA008
- 999 __
- $a ok $b bmc $g 1018300 $s 849744
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 102 $c 9 $d 2995-3017 $i 1520-6017 $m Journal of pharmaceutical sciences $n J Pharm Sci $x MED00002895
- LZP __
- $a Pubmed-20140401